Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis have?
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis has 1,005 citations in the OpenAlex counts ScholarIQ stores.
When was Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis published?
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis has 2020 year in the ScholarIQ index.
What is the open-access status of Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis?
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis has bronze oa status in the ScholarIQ index.
What is the DOI of Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis?
The DOI for Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis is on the source record.
What is the PMID of Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis?
The PMID for Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis is on the source record.
What is the OpenAlex record for Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis?
The OpenAlex for Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis is on the source record.